SEC Form 5 · accession 0001593968-19-000408
Adamis Pharmaceuticals Corp · ADMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eddie Wabern Glover
Officer — CEO of US Compounding, Inc.
Period of report
Dec 31, 2018
Accepted (ET)
Feb 12, 2019 · 6:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000887247
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 4, 2018 | G | 41,666 | $0.00 | D | 741,668 | D |
Table II — derivative securities
No Table II lines on this filing.